ClinicalTrials.Veeva

Menu

Drug-Eluting Balloon Registry in Routine Clinical Practice (IRIS DEB)

S

Seung-Jung Park

Status

Enrolling

Conditions

Coronary Artery Disease
Angioplasty, Balloon

Treatments

Device: Balloon angioplasty

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02038660
AMCCV2013-10

Details and patient eligibility

About

The purpose of this study is to evaluate long-term effectiveness and safety of patients with coronary disease treated with drug eluting balloon in real world practice.

Enrollment

1,500 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • After pre dilatation residual stenosis 30% and less and also without vessel dissection interrupted blood flow
  • Age 20 and more
  • Treated with Balloon angioplasty
  • Signed informed consent and agreed to follow protocol

Exclusion criteria

  • Allergy to paclitaxel, antiplatelet
  • History of side effect to heparin, aspirin, thienopyridines
  • History of bleeding tendency, coagulation disorder, blood transfusion reaction

Trial design

1,500 participants in 1 patient group

Patients with coronary artery disease
Treatment:
Device: Balloon angioplasty

Trial contacts and locations

8

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems